SMS Lifesciences Quarterly Results for Trading Insights
SMSLIFE • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹4 Cr
QMar 2025
SMS Lifesciences Quarterly Results Key Highlights
- Revenue of ₹92 Cr in Mar 2025 (+9.5% vs Jun 2025, +0.0% vs Mar 2024)
- Net Profit of ₹4 Cr in Mar 2025 (+0.0% vs Jun 2025, -42.9% vs Mar 2024)
- EBITDA of ₹10 Cr in Mar 2025 (-23.1% vs Jun 2025)
- Operating Margin of 8.0% in Mar 2025 (-6.0pp vs Jun 2025)
- Earnings Per Share of ₹9.83 in Mar 2025 (-28.5% vs Jun 2025)
SMS Lifesciences Quarterly Results Analysis
| Metric | Mar 2025 | Jun 2025 | Sept 2024 | Mar 2024 | Jun 2024 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 92 | 84 | 81 | 92 | 93 | 9.5% | - |
| Net Profit (₹ Cr) | 4 | 4 | 3 | 7 | 7 | - | - |
| EBITDA (₹ Cr) | 10 | 13 | 11 | 14 | 17 | - | - |
| EPS (₹) | 9.83 | 13.75 | 15.46 | 19.53 | 23.15 | - | - |
| Operating Margin (%) | 8.0% | 14.0% | 11.0% | 13.0% | 18.0% | - | - |
SMS Lifesciences Share Price Trend Around Quarterly Results
Visualize SMS Lifesciences's 1-year price movement across quarterly results — ideal for logging trades in SMS Lifesciences share price
chart using Tickjournal. All values in ₹.
Related Pages for SMS Lifesciences
Additional stock information and data for SMSLIFE
Revenue Trend (₹ Cr)
Mar 2024
92
Sept 2024
81
Jun 2025
84
Mar 2025
92
Net Profit Trend (₹ Cr)
Mar 2024
7
Sept 2024
3
Jun 2025
4
Mar 2025
4
Operating Margin Trend (%)
Mar 2024
13.0%
Sept 2024
11.0%
Jun 2025
14.0%
Mar 2025
8.0%
Sector Competitors - Quarterly Performance Comparison
Comparing SMS Lifesciences quarterly results with other companies in Healthcare sector
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Sun Pharmaceutical
Sept 2025 |
₹417,052.40 Cr | 1729.9 | 14,875 | 3,125 | +10.8% | - | 21.0% | 133.1 |
|
Divis Laboratories
Sept 2025 |
₹176,337.50 Cr | 6616.5 | 2,860 | 689 | +7.1% | - | 24.1% | 254.8 |
|
Torrent Pharmaceuti…
Sept 2025 |
₹136,522.12 Cr | 3963.4 | 3,219 | 591 | +11.3% | - | 18.4% | 226.0 |
|
Cipla
Sept 2025 |
₹118,572.82 Cr | 1465.7 | 7,716 | 1,353 | +12.0% | - | 17.5% | 87.6 |
|
Dr Reddys Laborator…
Sept 2025 |
₹100,998.62 Cr | 1210.1 | 9,135 | 1,337 | +1.1% | - | 14.6% | 74.8 |
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores
All amounts in ₹ Crores